Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine
- PMID: 3774129
- DOI: 10.1016/0028-3908(86)90204-2
Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine
Abstract
Intraventricular microinjection (5 micrograms) of the bisquaternary ganglion-blocking drug chlorisondamine prevented acquisition of nicotine-induced conditioned taste aversion (CTA) in rats. This appeared to be a specific effect because chlorisondamine did not attenuate the conditioned taste aversion caused by apomorphine. These results support findings from other behavioural procedures indicating that centrally administered chlorisondamine causes a long-term blockade of central nicotinic mechanisms.